HCPCS Service Codes - Medical care

HCPCS Service Code 1 for Medical care.

HCPCS Type of Service (TOS) code is an indicator that the contractor places on Form CMS-1500. The indicator is mainly used for data purposes, however in some instances, it affects payment. All HCPCS codes have a corresponding TOS indicator.

Below are all available HCPCS TOS codes. Find an HCPCS code based on the type of service.

HCPCS Codes for Medical care

  • J2275

    Injection, morphine sulfate (preservative-free sterile solution), per 10 mg

  • J2277

    Injection, motixafortide, 0.25 mg

  • J2278

    Injection, ziconotide, 1 microgram

  • J2280

    Injection, moxifloxacin, 100 mg

  • J2281

    Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg

  • J2290

    Injection, nafcillin sodium, 20 mg

  • J2291

    Injection, nafcillin sodium (baxter), 20 mg

  • J2300

    Injection, nalbuphine hydrochloride, per 10 mg

  • J2305

    Injection, nitroglycerin, 5 mg

  • J2310

    Injection, naloxone hydrochloride, per 1 mg

  • J2311

    Injection, naloxone hydrochloride (zimhi), 1 mg

  • J2312

    Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg

  • J2313

    Injection, naloxone hydrochloride (zimhi), 0.01 mg

  • J2315

    Injection, naltrexone, depot form, 1 mg

  • J2320

    Injection, nandrolone decanoate, up to 50 mg

  • J2323

    Injection, natalizumab, 1 mg

  • J2325

    Injection, nesiritide, 0.1 mg

  • J2326

    Injection, nusinersen, 0.1 mg

  • J2327

    Injection, risankizumab-rzaa, intravenous, 1 mg

  • J2329

    Injection, ublituximab-xiiy, 1mg

  • J2350

    Injection, ocrelizumab, 1 mg

  • J2351

    Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq

  • J2353

    Injection, octreotide, depot form for intramuscular injection, 1 mg

  • J2354

    Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg

  • J2355

    Injection, oprelvekin, 5 mg

  • J2356

    Injection, tezepelumab-ekko, 1 mg

  • J2357

    Injection, omalizumab, 5 mg

  • J2358

    Injection, olanzapine, long-acting, 1 mg

  • J2359

    Injection, olanzapine, 0.5 mg

  • J2360

    Injection, orphenadrine citrate, up to 60 mg

  • J2361

    Injection, depemokimab-ulaa, 1 mg

  • J2370

    Injection, phenylephrine hcl, up to 1 ml

  • J2371

    Injection, phenylephrine hydrochloride, 20 micrograms

  • J2372

    Injection, phenylephrine hydrochloride (biorphen), 20 micrograms

  • J2373

    Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms

  • J2374

    Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml

  • J2400

    Injection, chloroprocaine hydrochloride, per 30 ml

  • J2401

    Injection, chloroprocaine hydrochloride, per 1 mg

  • J2402

    Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg

  • J2403

    Chloroprocaine hcl ophthalmic, 3% gel, 1 mg

  • J2404

    Injection, nicardipine, 0.1 mg

  • J2405

    Injection, ondansetron hydrochloride, per 1 mg

  • J2406

    Injection, oritavancin (kimyrsa), 10 mg

  • J2407

    Injection, oritavancin (orbactiv), 10 mg

  • J2410

    Injection, oxymorphone hcl, up to 1 mg

  • J2425

    Injection, palifermin, 50 micrograms

  • J2426

    Injection, paliperidone palmitate extended release (invega sustenna), 1 mg

  • J2427

    Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg

  • J2428

    Injection, paliperidone palmitate extended release (erzofri), 1 mg

  • J2430

    Injection, pamidronate disodium, per 30 mg